EUVIMEDEUVIMED entdecken
Crossref

Extravascular CD3+ T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical Study

Mario Merlini, Tunahan Kirabali, Luka Kulic, Roger M Nitsch, Maria Teresa Ferretti

Neurodegenerative Diseases · 2018 · 18 (1) · 49-56

DOI: 10.1159/000486200 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurodegenerative Diseases, online erschienen am 07.02.2018. Verfasst von Mario Merlini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Regenerative Medicine (IREM), University of Zurich, Switzerland Neuroscience Center Zurich (ZNZ), Zurich, Switzerland. Die Arbeit wurde bisher 209-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Strong genetic and epidemiological evidence points to a crucial role of the immune system in the development of Alzheimer disease (AD). CD3+ T lymphocytes have been described in brains of postmortem AD patients and in transgenic models of AD-like cerebral amyloidosis and tau pathology. However, the occurrence of T cells in AD brains is still controversial; furthermore, the relationship between T cells and hallmarks of AD pathology (amyloid plaques and neurofibrillary tangles) remains to be established.

Objectives

We have studied the occurrence of T cells in postmortem hippocampi and mid frontal gyrus (MFG) samples of AD patients (Braak stage V-VI) and nondemented control subjects and correlated it with amyloid and tau pathology burden.

Methods

Confocal microscopy and bright-field immunohistochemistry were used to identify brain-associated T cells. Extravascular CD3+ T cells were quantified and compared to nondemented controls. In addition, numbers of extravascular CD3+ T cells were correlated with amyloid (6E10 staining) and tau pathology (AT8 staining) in the same sections.

Results

Several CD3+, extravascular T cells were observed in the brains of AD patients, mostly of the CD8+ subtype. AD hippocampi harbored significantly increased numbers of extravascular CD3+ T cells compared to nondemented controls. CD3+ T cells significantly correlated with tau pathology but not with amyloid plaques in AD samples.

Conclusions

Our data support the notion of T-cell occurrence in AD brains and suggest that, in advanced stages of AD, T-cell extravasation is driven by tau-related neurodegenerative changes rather than by cerebral amyloidosis. T cells could be crucial for driving the amyloid-independent phase of the AD pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aged, 80 and overAlzheimer DiseaseBrainCD3 ComplexFemaleHumansMalePlaque, AmyloidT-Lymphocytes

Stichwörter der Autor:innen

6E10AT8Alzheimer diseaseAmyloidCD3HippocampusMid frontal gyrusT cellsTau

Substanzen

CD3 Complex

Autor:innen und Institutionen

  • Institute for Regenerative Medicine (IREM), University of Zurich, Switzerland Neuroscience Center Zurich (ZNZ), Zurich, Switzerland.

Zitieren

APA

Merlini, M., Kirabali, T., Kulic, L., Nitsch, R. M., & Ferretti, M. T. (2018). Extravascular CD3+ T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical Study. Neurodegenerative Diseases, 18(1), 49-56. https://doi.org/10.1159/000486200

Vancouver

Merlini M, Kirabali T, Kulic L, Nitsch RM, Ferretti MT. Extravascular CD3+ T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical Study. Neurodegenerative Diseases. 2018;18(1):49-56. doi:10.1159/000486200

BibTeX
@article{Merlini2018,
  author = {Merlini, Mario and Kirabali, Tunahan and Kulic, Luka and Nitsch, Roger M and Ferretti, Maria Teresa},
  title = {Extravascular CD3+ T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical Study},
  journal = {Neurodegenerative Diseases},
  year = {2018},
  volume = {18},
  number = {1},
  pages = {49--56},
  doi = {10.1159/000486200}
}
Kostenlos starten →